News
Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.
Latest Coverage
30 headlines
Hyunsu Jung, CEO of Hyperion DeFi, Inc., stressed the company's goal of steadily growing its Hyperliquid reserve, noting that greater HYPE ownership is beneficial.
Filed: 2026-09-09 AccNo: 0001213900-26-098204 Size: 226 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-09 AccNo: 0001907982-26-000144 Size: 425 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Kirby McInerney LLP is reminding PROCEPT BioRobotics investors of the September 22, 2026 deadline to seek lead plaintiff status in a federal securities class action. The lawsuit alleges the company made false statements about handpiece unit sales by concealing an extensive discount program that artificially inflated revenues and created over 10,000 excess units in field inventory. Stock declined significantly following earnings misses and guidance reductions in August, November 2025, and February 2026.
Rosen Law Firm is notifying investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) of a securities class action lawsuit with a September 22, 2026 lead plaintiff deadline. The lawsuit alleges that PROCEPT made materially false statements regarding its sales practices, including use of undisclosed discount programs that artificially inflated handpiece unit sales and revenues, created excess inventory of over 10,000 units, and made unachievable 2025 guidance. Investors with losses exceeding $100,000 are encouraged to seek counsel.
Kirby McInerney LLP is reminding EquipmentShare.com Inc. investors of the September 21, 2026 deadline to seek lead plaintiff status in a securities fraud class action. The lawsuit alleges the company made materially false statements regarding undisclosed related-party transactions totaling at least $77 million. Following a short-seller report in June 2026, EquipmentShare's stock declined over 34.5% from its $24.50 IPO price to $16.06.
Rivian's CFO Claire McDonough is departing for GE Vernova after nearly six years, but the transition is orderly and reflects the company's evolution from startup fundraising to mass manufacturing. In contrast, Lucid is experiencing a severe executive exodus under new CEO Silvio Napoli, including the departure of founder Peter Rawlinson, CFO Taoufiq Boussaid, and multiple senior engineers. Lucid's sweeping restructuring, layoffs, and delayed product launches signal deeper troubles, making Rivian appear the more stable long-term EV investment.
Rithm (RITM) declined 1.29% to $9.95, underperforming the S&P 500's 0.58% loss. The real estate investment trust faces a projected 5.56% EPS decline for the upcoming quarter, though revenue is expected to rise 33.3% year-over-year. The stock holds a Zacks Rank #3 (Hold) with a Forward P/E of 4.46, trading at a discount to its industry average of 11.91.
SEOOnly, founded by marketing entrepreneur Preeti Kennedy, has launched as a specialist search visibility firm focused on helping businesses adapt to AI-driven search and changing customer discovery patterns. The company operates exclusively on search optimization across traditional search engines and AI platforms like ChatGPT and Gemini, rather than offering SEO as one service among many.
Micware Co., Ltd. and MulticoreWare, Inc. have signed a Memorandum of Understanding to explore collaboration on AI solutions for advanced driver assistance systems (ADAS), in-vehicle user experience, and edge AI. The partnership combines Micware's automotive OEM relationships and software expertise with MulticoreWare's capabilities in heterogeneous hardware optimization and AI integration. The MOU, effective until June 8, 2027, covers technical cooperation, physical AI integration, business development in Japan, and joint marketing activities, though no definitive agreements have been concluded.
Nucor stock declined 1.79% on September 8, 2026, underperforming the S&P 500's 0.58% loss and lagging the Basic Materials sector. Despite strong earnings projections showing 107.60% EPS growth and 22.4% revenue growth for the upcoming quarter, the stock has lost 4.93% over the past month. Nucor holds a Zacks Rank #3 (Hold) with a Forward P/E of 14.54, slightly above its industry average.
Lennar stock fell 3.84% in the latest trading session, underperforming the broader market. The homebuilder faces headwinds with projected EPS declining 34.5% and revenue down 5.42% for the upcoming quarter. The company carries a Zacks Rank of #4 (Sell) and trades at a premium valuation compared to its industry peers.
American Airlines stock fell 1.68% on September 8, 2026, underperforming the S&P 500's 0.58% decline. The airline has lost 12.47% over the past month, significantly trailing the broader market. Upcoming earnings are projected to show a loss of $0.32 per share with an 88.24% year-over-year decline, though revenue is expected to grow 17.77%. The stock holds a Zacks Rank of #3 (Hold), and the airline industry ranks in the bottom 16% of all industries.
Bristol Myers Squibb's SOTYKTU (deucravacitinib), a first-in-class TYK2 inhibitor, has received FDA approval for psoriatic arthritis in March 2026, expanding its commercial potential beyond plaque psoriasis. The drug demonstrates sustained efficacy with PASI 75 response rates of 67%-73% through five years and over 5,000 patient-years of safety data. Market analysis forecasts SOTYKTU sales across seven major markets through 2034, with growth driven by oral convenience, selective mechanism of action, and potential expansion into additional immune-mediated inflammatory disease indications including lupus, Sjogren's syndrome, and Crohn's disease.
Rosen Law Firm is reminding investors who purchased securities of Wix.com Ltd. (NASDAQ: WIX) between February 19, 2025 and May 12, 2026 of an important September 22, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Wix made false and misleading statements regarding its AI product offerings, overstating their competitiveness and performance while understating development costs, resulting in materially false financial representations.
Cogent Communications Holdings faces a securities fraud class action lawsuit for allegedly failing to disclose material information about its optical wavelength backlog and demand issues during February 29, 2024 to May 1, 2026. The company allegedly misrepresented customer demand, backlog viability, and financial capacity to maintain its dividend policy. Investors who purchased shares during this period have until September 21, 2026 to file lead plaintiff applications.
Rosen Law Firm is urging investors in Aardvark Therapeutics (AARD) to join a securities class action lawsuit with an October 13, 2026 deadline for lead plaintiff claims. The lawsuit alleges that defendants made materially false statements about the safety and prospects of their drug ARD-101, and failed to disclose material adverse facts about the company's business and operations.
Jeff Bezos maintains his position as Amazon's largest shareholder with approximately 950.4 million shares worth $245.7 billion, representing 8.8% of outstanding shares. While Amazon's stock has gained 12% year-to-date, it has underperformed the S&P 500's 13.7% return. However, the company's strong fundamentals, particularly AWS's 36.8% year-over-year growth and 60.5% operating income contribution, suggest long-term growth potential justifies including Amazon in a diversified portfolio.
A class action securities lawsuit has been filed against AEVEX Corp. alleging that the company and its executives concealed a pre-arranged plan with Madison and underwriters to prematurely override a 180-day lock-up period following its April 2026 IPO. The alleged scheme enabled Madison to sell over $200 million in shares and underwriters to collect $8+ million in fees. Investors who purchased shares between April 17 and June 4, 2026 can join the lawsuit with an October 20, 2026 deadline to request lead plaintiff status.
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Intellia Therapeutics (NASDAQ:NTLA) with a Buy and maintains $25 price target.
This launch aims to enhance IPM's web hosting and managed services offerings by providing clients with a no-code, always-on, AI virtual assistant that is hosted within IPM's private cloud infrastructure,
Is AI-driven market exuberance irrational? Oaktree's Howard Marks weighs in on valuations, bubbles, and risk.
Filed: 2026-09-09 AccNo: 0000832988-26-000227 Size: 636 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Under the agreement, Centrus will begin delivering HALEU before the end of the decade, adding another domestic source of fuel to support commercial scale-up of Radiant's Kaleidos fleet.The contract further
Expansion reflects excess liquidity and consistent free cash conversion. After the completion of the anticipated ASR, approximately $575 million in share repurchase authorization would remain.
Baker Hughes (NASDAQ:BKR) raises FY2026 sales outlook from $26.200 billion-$28.300 billion to $28.500 billion-$30.300 billion vs $27.628 billion estimate.
J.Jill (NYSE:JILL) raises FY2026 sales outlook from $584.618 million-$596.549 million to $596.549 million-$608.480 million vs $590.260 million estimate.
Signet Jewelers (NYSE:SIG) sees Q3 sales of $1.370 billion-$1.410 billion vs $1.393 billion analyst estimate.
Signet Jewelers (NYSE:SIG) raises FY2027 Adj EPS guidance from $9.20-$11.00 to $10.45-$12.12 vs $10.82 analyst estimate. Affirms FY2027 sales outlook from $6.700 billion-$6.900 billion to $6.700 billion-$6.900 billion
Signet Jewelers (NYSE:SIG) reported quarterly earnings of $2.19 per share which beat the analyst consensus estimate of $1.74 by 25.86 percent. This is a 36.02 percent increase over earnings of $1.61 per share from the